Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy.
Intravenous heparin is routinely given after thrombolytic therapy for patients with acute myocardial infarction in the United States and in some, but by no means all, other countries. Several trials have documented improved infarct-artery patency in patients treated with heparin; however, none was l...
Autors principals: | Mahaffey, K, Granger, C, Collins, R, O'Connor, C, Ohman, E, Bleich, S, Col, J, Califf, R |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
1996
|
Ítems similars
-
Low-molecular heparins in thrombolytic therapy of myocardial infarction patients
per: I. S. Yavelov
Publicat: (2009-12-01) -
Intravenous thrombolytic therapy in myocardial infarction (review)
per: I I Staroverov
Publicat: (2003-10-01) -
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
per: Collins, R, et al.
Publicat: (1987) -
RANDOMIZED FACTORIAL TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
per: Collins, R
Publicat: (1987) -
HEPARIN IN THE PRESENCE OR ABSENCE OF ANTIPLATELET THERAPY - AN OVERVIEW OF RANDOMIZED TRIALS IN ACUTE MYOCARDIAL-INFARCTION
per: Macmahon, S, et al.
Publicat: (1992)